Covered recipient · General Payments record
ANDREW C GIN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$6,375.39
- Reported across 336 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $485.85 | 22 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $170.48 | 8 |
| Neurocrine BioSciences, Inc. | $120.57 | 5 |
| PFIZER INC. | $70.68 | 3 |
| Amneal Pharmaceuticals LLC | $41.88 | 2 |
| EISAI INC. | $28.51 | 1 |
| Lundbeck LLC | $23.33 | 1 |
| Teva Pharmaceuticals USA, Inc. | $16.76 | 1 |
| Lilly USA, LLC | $13.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (22)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.02 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103799894 | CMS |
| ABBVIE INC. | $21.26 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103799896 | CMS |
| ABBVIE INC. | $27.20 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103799898 | CMS |
| ABBVIE INC. | $9.35 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103799900 | CMS |
| ABBVIE INC. | $21.87 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103799902 | CMS |
| ABBVIE INC. | $20.00 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103799904 | CMS |
| ABBVIE INC. | $23.03 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103799906 | CMS |
| ABBVIE INC. | $20.75 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103799908 | CMS |
| Amneal Pharmaceuticals LLC | $18.71 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139186836 | CMS |
| Amneal Pharmaceuticals LLC | $23.17 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139186838 | CMS |
| Eisai Inc. | $28.51 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110729413 | CMS |
| Lilly USA, LLC | $13.64 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136035326 | CMS |
| Lundbeck LLC | $23.33 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145918949 | CMS |
| Neurocrine Biosciences, Inc. | $24.70 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150840794 | CMS |
| Neurocrine Biosciences, Inc. | $25.98 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150837062 | CMS |
| Neurocrine Biosciences, Inc. | $20.20 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150858079 | CMS |
| Neurocrine Biosciences, Inc. | $22.55 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150848392 | CMS |
| Neurocrine Biosciences, Inc. | $27.14 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150833386 | CMS |
| PFIZER INC. | $27.53 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131172931 | CMS |
| PFIZER INC. | $16.72 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131172935 | CMS |
| PFIZER INC. | $26.43 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131399789 | CMS |
| Teva Pharmaceuticals USA, Inc. | $16.76 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151745617 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.